BCTG Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BCTG and buy or sell other stocks, ETFs, and their options commission-free!About BCTG
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need.
CEOBarbara L. Weber, MD
CEOBarbara L. Weber, MD
Employees155
Employees155
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2017
Founded2017
Employees155
Employees155
BCTG Key Statistics
Market cap1.14B
Market cap1.14B
Price-Earnings ratio-9.41
Price-Earnings ratio-9.41
Dividend yield—
Dividend yield—
Average volume3.02M
Average volume3.02M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$11.20
52 Week high$11.20
52 Week low$1.03
52 Week low$1.03
Stock Snapshot
With a market cap of 1.14B, BCTG Acquisition(BCTG) trades at $10.20. The stock has a price-to-earnings ratio of -9.41.
BCTG Acquisition(BCTG) stock opened on 2025-12-23 at —. The price climbed to — and dipped to —.
BCTG Acquisition(BCTG) shares are trading with a volume of 0, against a daily average of 3.02M.
In the last year, BCTG Acquisition(BCTG) shares hit a 52-week high of $11.20 and a 52-week low of $1.03.
In the last year, BCTG Acquisition(BCTG) shares hit a 52-week high of $11.20 and a 52-week low of $1.03.
People also own
Based on the portfolios of people who own BCTG. This list is generated using Robinhood data, and it’s not a recommendation.